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Abstract
P2X receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on P2X Receptors [46, 134])
have a trimeric topology [118, 132, 177] with two putative TM domains, gating primarily Na+, K+ and Ca2+,
exceptionally Cl-. The Nomenclature Subcommittee has recommended that for P2X receptors, structural criteria
should be the initial criteria for nomenclature where possible. X-ray crystallography indicates that functional P2X
receptors are trimeric and three agonist molecules are required to bind to a single receptor in order to activate it
[132, 88, 96, 161]. Native receptors may occur as either homotrimers (e.g. P2X1 in smooth muscle) or
heterotrimers (e.g. P2X2:P2X3 in the nodose ganglion [251], P2X1:P2X5 in mouse cortical astrocytes [146], and
P2X2:P2X5 in mouse dorsal root ganglion, spinal cord and mid pons [50, 207]. P2X2, P2X4 and P2X7 receptors
have been shown to form functional homopolymers which, in turn, activate pores permeable to low molecular
weight solutes [229]. The hemi-channel pannexin-1 has been implicated in the pore formation induced by P2X7
[188], but not P2X2 [38], receptor activation.
Contents
This is a citation summary for P2X receptors in the Guide to Pharmacology database (GtoPdb). It exists purely
as an adjunct to the database to facilitate the recognition of citations to and from the database by citation
analyzers. Readers will almost certainly want to visit the relevant sections of the database which are given here
under database links.
GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a
reference work which is most usefully represented as an on-line database. As in any publication this work
should be appropriately cited, and the papers it cites should also be recognized. This document provides a
citation for the relevant parts of the database, and also provides a reference list for the research cited by those
parts.
Please note that the database version for the citations given in GtoPdb are to the most recent preceding version
in which the family or its subfamilies and targets were substantially changed. The links below are to the current
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